Nail Lichen Planus: Successful Treatment with Etanercept

Irla, N; Schneiter, T; Haneke, E; Yawalkar, N (2010). Nail Lichen Planus: Successful Treatment with Etanercept. Case reports in dermatology, 2(3), pp. 173-176. Basel: Karger

Full text not available from this repository. (Request a copy)

BACKGROUND: Etanercept is a fully human tumor necrosis factor a receptor fusion protein that binds tumor necrosis factor a with greater affinity than natural receptors. Biologics are widely used in the treatment of psoriasis and psoriasis arthritis and may represent a new therapeutic option for some patients with psoriatic nail disease. CASE REPORT: We report a case of lichen planus limited to the toe nails successfully treated with etanercept monotherapy. CONCLUSION: The significant improvement of our case suggests that etanercept is an effective treatment modality for lichen planus limited particularly to the nails. Further controlled studies are needed to establish the effectiveness and therapeutic regimes.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Irla, Nathalie; Schneiter, Thomas; Haneke, Eckart and Yawalkar, Nikhil

ISSN:

1662-6567

Publisher:

Karger

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:12

Last Modified:

06 Dec 2013 13:22

PubMed ID:

21113341

URI:

https://boris.unibe.ch/id/eprint/2273 (FactScience: 204665)

Actions (login required)

Edit item Edit item
Provide Feedback